Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Comparison of the clinical manifestations and histopathological results in leprosy: A 5-year retrospective study in a tertiary hospital

Sari ARP, Siswati AS, Ferronika P, et al. Lepra. Leprosy Review. 2024; 95 (4) : 1-7.
Download PDF
Publication

One Health approaches to tackling antimicrobial resistance

Woolhouse M. Elsevier BV. Science in One Health. 2024;
Download PDF
Practical material

New guidance to accelerate elimination of schistosomiasis and intestinal helminthiasis

World Health Organization . 2024;
Access resource
Publication

Doenças Negligenciadas na Região Sul do Ceará: Um Desafio Persistente no Nordeste Brasileiro

Lima AG, Beserra AT, Jerônimo GAC, et al. Brazilian Journals. Brazilian Journal of Biological Sciences. 2024; 11 (25) : 1-9.
Download PDF
Publication

Impact of climate change on the rights of people affected by leprosy-related disability: a human rights approach

Ahmed A. African Journal of Law, Ethics and Education. 2024;
Download PDF
Publication

Factors Associated with Mental Health Care Utilization among Neglected Tropical Disease Patients in Three Central Cameroon Healthcare Districts

Victorine O, Yvonne B, Inna M, et al. International Research in Medical and Health Sciences. 2024;
Download PDF
Publication

Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World

Cosma C, Maia C, Khan N, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2024; 9 (11) : 1-18.
Download PDF
Publication

India eliminates trachoma as a public health problem – What lies ahead?

Vanathi M. Indian Journal of Ophthalmology. 2024;
Download PDF
Publication

Drugs for Vector-Borne Protozoal Diseases in a One Health Scenario. A European Perspective

Cordeiro da Silva A, Calogeropoulou T, Costi MP, et al. American Chemical Society (ACS). ACS Infectious Diseases. 2024;
Download PDF
Publication

Combination Therapy for Post-Kala-Azar Dermal Leishmaniasis: A Literature Review of Current Evidence

Kumari A, Siddiqui NA, Kumari S, et al. Medknow. Indian Journal of Dermatology. 2024; 69 (5) : 396-405.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 61
  • Next page ››
Subscribe to Full text online

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD